• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清脂质组学揭示了与束带术相比,胃旁路手术对磷脂和鞘脂的早期差异影响,且这种影响独立于体重减轻的差异。

Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss.

作者信息

Kayser B D, Lhomme M, Dao M C, Ichou F, Bouillot J-L, Prifti E, Kontush A, Chevallier J-M, Aron-Wisnewsky J, Dugail I, Clément K

机构信息

Nutriomics Team, Institute of Cardiometabolism and Nutrition, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France.

Nutriomics Team, INSERM, UMR S U1166, Paris, France.

出版信息

Int J Obes (Lond). 2017 Jun;41(6):917-925. doi: 10.1038/ijo.2017.63. Epub 2017 Mar 10.

DOI:10.1038/ijo.2017.63
PMID:28280270
Abstract

BACKGROUND/OBJECTIVES: Circulating phospholipids and sphingolipids are implicated in obesity-related comorbidities such as insulin resistance and cardiovascular disease. How bariatric surgery affects these important lipid markers is poorly understood. We sought to determine whether Roux-en-Y gastric bypass (RYGB), which is associated with greater metabolic improvement, differentially affects the phosphosphingolipidome compared with adjustable gastric banding (AGB).

SUBJECTS/METHODS: Fasting sera were available from 59 obese women (body mass index range 37-51 kg m; n=37 RYGB and 22 AGB) before surgery, then at 1 (21 RYGB, 12 AGB) and 3 months follow-up (19 RYGB, 12 AGB). HPLC-MS/MS was used to quantify 131 lipids from nine structural classes. DXA measurements and laboratory parameters were also obtained. The associations between lipids and clinical measurements were studied with P-values adjusted for the false discovery rate (FDR).

RESULTS

Both surgical procedures rapidly induced weight loss and improved clinical profiles, with RYGB producing better improvements in fat mass, and serum total cholesterol, low-density lipoprotein-cholesterol (LDL-C) and orosomucoid (FDR <10%). Ninety-three (of 131) lipids were altered by surgery-the majority decreasing-with 29 lipids differentially affected by RYGB during the study period. The differential effect of the surgeries remained statistically significant for 20 of these lipids after adjusting for differences in weight loss between surgery types. The RYGB signature consisted of phosphatidylcholine species not exceeding 36 carbons, and ceramides and sphingomyelins containing C22 to C25 fatty acids. RYGB also led to a sustained increase in unsaturated ceramide and sphingomyelin species. The RYGB-specific lipid changes were associated with decreases in body weight, total and LDL-C, orosomucoid and increased HOMA-S (FDR <10%).

CONCLUSIONS

Concomitant with greater metabolic improvement, RYGB induced early and sustained changes in phosphatidylcholines, sphingomyelins and ceramides that were independent of greater weight loss. These data suggest that RYGB may specifically alter sphingolipid metabolism, which, in part, could explain the better metabolic outcomes of this surgical procedure.

摘要

背景/目的:循环中的磷脂和鞘脂与肥胖相关的合并症有关,如胰岛素抵抗和心血管疾病。减肥手术如何影响这些重要的脂质标志物,目前尚不清楚。我们试图确定与更好的代谢改善相关的 Roux-en-Y 胃旁路术(RYGB)与可调节胃束带术(AGB)相比,是否对磷酸鞘脂组有不同的影响。

受试者/方法:收集了 59 名肥胖女性(体重指数范围为 37 - 51 kg/m²;37 例行 RYGB,22 例行 AGB)术前、术后 1 个月(21 例行 RYGB,12 例行 AGB)和 3 个月随访(19 例行 RYGB,12 例行 AGB)时的空腹血清。采用高效液相色谱-串联质谱法(HPLC-MS/MS)对 9 种结构类别的 131 种脂质进行定量分析。还进行了双能 X 线吸收测定(DXA)和实验室参数检测。通过对错误发现率(FDR)进行校正的 P 值研究脂质与临床测量值之间的关联。

结果

两种手术均迅速导致体重减轻并改善临床指标,RYGB 在减少脂肪量、血清总胆固醇、低密度脂蛋白胆固醇(LDL-C)和血清类黏蛋白方面改善更明显(FDR < 10%)。手术改变了 131 种脂质中的 93 种(大多数脂质减少),在研究期间有 29 种脂质受到 RYGB 的不同影响。在调整手术类型之间体重减轻的差异后,其中 20 种脂质的手术差异效应仍具有统计学意义。RYGB 的特征性脂质包括碳数不超过 36 的磷脂酰胆碱种类,以及含有 C22 至 C25 脂肪酸的神经酰胺和鞘磷脂。RYGB 还导致不饱和神经酰胺和鞘磷脂种类持续增加。RYGB 特异性的脂质变化与体重、总胆固醇和 LDL-C、血清类黏蛋白的降低以及胰岛素抵抗稳态模型评估(HOMA-S)的增加相关(FDR < 10%)。

结论

与更好的代谢改善同时出现的是,RYGB 诱导了磷脂酰胆碱、鞘磷脂和神经酰胺的早期和持续变化,这些变化独立于更大程度的体重减轻。这些数据表明,RYGB 可能特异性地改变鞘脂代谢,这在一定程度上可以解释该手术更好的代谢效果。

相似文献

1
Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss.血清脂质组学揭示了与束带术相比,胃旁路手术对磷脂和鞘脂的早期差异影响,且这种影响独立于体重减轻的差异。
Int J Obes (Lond). 2017 Jun;41(6):917-925. doi: 10.1038/ijo.2017.63. Epub 2017 Mar 10.
2
Essential Fatty Acid Plasma Profiles Following Gastric Bypass and Adjusted Gastric Banding Bariatric Surgeries.胃旁路手术和改良胃束带减肥手术后的必需脂肪酸血浆谱
Obes Surg. 2016 Jun;26(6):1237-46. doi: 10.1007/s11695-015-1876-3.
3
Different effects of bariatric surgical procedures on dyslipidemia: a registry-based analysis.不同减重手术方式对血脂异常的影响:基于注册登记的分析。
Surg Obes Relat Dis. 2017 Jul;13(7):1189-1194. doi: 10.1016/j.soard.2017.03.013. Epub 2017 Mar 23.
4
The Effect of Bariatric Surgery Type on Lipid Profile: An Age, Sex, Body Mass Index and Excess Weight Loss Matched Study.减肥手术类型对血脂谱的影响:一项年龄、性别、体重指数和体重减轻匹配的研究。
Obes Surg. 2016 May;26(5):1041-7. doi: 10.1007/s11695-015-1825-1.
5
Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.胃旁路术与可调胃束带术治疗非酒精性脂肪性肝病的 5 年对照纵向研究。
Ann Surg. 2014 Nov;260(5):893-8; discussion 898-9. doi: 10.1097/SLA.0000000000000945.
6
Primary Roux-en-Y Gastric Bypass Results in Greater Weight Loss at 15-Year Follow-Up Compared with Secondary Roux-en-Y Gastric Bypass After Failure of Gastric Band or Mason McLean Vertical Gastroplasty.与胃束带术或梅森·麦克林垂直胃成形术失败后进行的二次Roux-en-Y胃旁路术相比,初次Roux-en-Y胃旁路术在15年随访时减重效果更佳。
Obes Surg. 2020 Oct;30(10):3655-3668. doi: 10.1007/s11695-020-04728-5.
7
Effect of primary versus revisional Roux-en-Y gastric bypass: inferior weight loss of revisional surgery after gastric banding.初次与再次 Roux-en-Y 胃旁路术的效果:胃旁路术后胃带调整的再次手术减重效果较差。
Surg Obes Relat Dis. 2013 Mar-Apr;9(2):253-8. doi: 10.1016/j.soard.2012.01.022. Epub 2012 Mar 7.
8
Changes in Gut Microbiome after Bariatric Surgery Versus Medical Weight Loss in a Pilot Randomized Trial.减肥手术后与医学减肥法对肠道微生物组影响的初步随机试验
Obes Surg. 2019 Oct;29(10):3239-3245. doi: 10.1007/s11695-019-03976-4.
9
Effects of Sleeve Gastrectomy and Gastric Bypass on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients: a 2-Year Follow-up.袖状胃切除术和胃旁路手术对肥胖2型糖尿病患者餐后血脂谱的影响:一项为期2年的随访研究
Obes Surg. 2016 Jun;26(6):1247-53. doi: 10.1007/s11695-015-1891-4.
10
Bariatric Surgery and Long-term Durability of Weight Loss.减肥手术与体重减轻的长期持久性
JAMA Surg. 2016 Nov 1;151(11):1046-1055. doi: 10.1001/jamasurg.2016.2317.

引用本文的文献

1
Circulating Lipid Profiles Indicate Incomplete Metabolic Recovery After Weight Loss, Suggesting the Need for Additional Interventions in Severe Obesity.循环脂质谱表明减肥后代谢未完全恢复,提示重度肥胖患者需要额外的干预措施。
Biomolecules. 2025 Aug 1;15(8):1112. doi: 10.3390/biom15081112.
2
Apolipoprotein M expression modifies the sphingolipid landscape in murine blood and lymph.载脂蛋白M的表达改变了小鼠血液和淋巴中的鞘脂格局。
Front Immunol. 2025 May 2;16:1572959. doi: 10.3389/fimmu.2025.1572959. eCollection 2025.
3
Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?

本文引用的文献

1
Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.胰岛素抵抗及相关代谢紊乱中的神经鞘脂类和磷脂。
Nat Rev Endocrinol. 2017 Feb;13(2):79-91. doi: 10.1038/nrendo.2016.169. Epub 2016 Oct 21.
2
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.血浆神经酰胺可预测稳定型冠状动脉疾病和急性冠状动脉综合征患者的心血管死亡,且独立于低密度脂蛋白胆固醇。
Eur Heart J. 2016 Jul 1;37(25):1967-76. doi: 10.1093/eurheartj/ehw148. Epub 2016 Apr 28.
3
Changes in Lipid Profile of Obese Patients Following Contemporary Bariatric Surgery: A Meta-Analysis.
鞘脂类在心脏代谢疾病中的新兴作用:合理的治疗靶点?
Nutrients. 2024 Sep 28;16(19):3296. doi: 10.3390/nu16193296.
4
Alterations of lipid homeostasis in morbid obese patients are partly reversed by bariatric surgery.病态肥胖患者脂质稳态的改变通过减肥手术部分得到逆转。
iScience. 2024 Aug 26;27(9):110820. doi: 10.1016/j.isci.2024.110820. eCollection 2024 Sep 20.
5
Precision Medicine in Bariatric Procedures.减重手术中的精准医学。
Gastrointest Endosc Clin N Am. 2024 Oct;34(4):765-779. doi: 10.1016/j.giec.2024.03.004. Epub 2024 Apr 16.
6
Brain-derived neurotrophic factor - a key player in the gastrointestinal system.脑源性神经营养因子——胃肠道系统中的关键因子。
Prz Gastroenterol. 2023;18(4):380-392. doi: 10.5114/pg.2023.132957. Epub 2023 Nov 20.
7
Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review.基于质谱的非癌症疾病血液代谢组学分析进展:综述
Metabolites. 2024 Jan 14;14(1):54. doi: 10.3390/metabo14010054.
8
Lipidome Profiling in Childhood Obesity Compared to Adults: A Pilot Study.儿童肥胖与成人肥胖的脂质组学特征比较:一项初步研究。
Nutrients. 2023 Jul 27;15(15):3341. doi: 10.3390/nu15153341.
9
Adjustable Intragastric Balloon Leads to Significant Improvement in Obesity-Related Lipidome and Fecal Microbiome Profiles: A Proof-of-Concept Study.可调式胃内球囊可显著改善肥胖相关脂质组学和粪便微生物组学特征:概念验证研究。
Clin Transl Gastroenterol. 2022 Jul 1;13(7):e00508. doi: 10.14309/ctg.0000000000000508. Epub 2022 Jun 7.
10
The Lard Works in Mysterious Ways: Ceramides in Nutrition-Linked Chronic Disease.猪油以神秘的方式发挥作用:神经酰胺与营养相关慢性疾病。
Annu Rev Nutr. 2022 Aug 22;42:115-144. doi: 10.1146/annurev-nutr-062220-112920. Epub 2022 May 18.
当代减重手术后肥胖患者血脂谱的变化:一项荟萃分析。
Am J Med. 2016 Sep;129(9):952-9. doi: 10.1016/j.amjmed.2016.02.004. Epub 2016 Feb 18.
4
Nutritional and Protein Deficiencies in the Short Term following Both Gastric Bypass and Gastric Banding.胃旁路手术和胃束带手术后短期内的营养及蛋白质缺乏情况
PLoS One. 2016 Feb 18;11(2):e0149588. doi: 10.1371/journal.pone.0149588. eCollection 2016.
5
Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity.神经酰胺合酶5对于维持C16:0-神经酰胺库至关重要,并促进饮食诱导的肥胖症的发展。
J Biol Chem. 2016 Mar 25;291(13):6989-7003. doi: 10.1074/jbc.M115.691212. Epub 2016 Feb 7.
6
Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans.休息和运动期间的肌肉鞘脂:人类胰岛素抵抗的C18:0特征
Diabetologia. 2016 Apr;59(4):785-98. doi: 10.1007/s00125-015-3850-y. Epub 2016 Jan 6.
7
Weight Change-Adjusted Effects of Gastric Bypass Surgery on Glucose Metabolism: 2- and 10-Year Results From the Swedish Obese Subjects (SOS) Study.胃旁路手术对葡萄糖代谢的体重变化调整效果:来自瑞典肥胖受试者(SOS)研究的 2 年和 10 年结果。
Diabetes Care. 2016 Apr;39(4):625-31. doi: 10.2337/dc15-1407. Epub 2015 Dec 17.
8
Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.血清鞘脂类:与人类胰岛素敏感性的关系及运动后的变化
Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E398-408. doi: 10.1152/ajpendo.00134.2015. Epub 2015 Jun 30.
9
Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.Roux-en-Y胃旁路手术可引发人体早期血浆代谢组学和脂质组学改变,这些改变与糖尿病缓解相关。
PLoS One. 2015 May 6;10(5):e0126401. doi: 10.1371/journal.pone.0126401. eCollection 2015.
10
The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes.肠道适应性在多种减肥手术对肥胖症和糖尿病的显著疗效中的作用。
Cell Metab. 2015 Mar 3;21(3):369-78. doi: 10.1016/j.cmet.2015.01.001. Epub 2015 Feb 5.